News/Events

Ashish Jejurkar (Partner)’s comment was quoted in an article entitled "ASIA’S NEW POWER COUPLE," in Asian Legal Business Asia Edition, March 2024, published by Thomson Reuters.

An article on the "NIKKEI Generative AI Symposium," in which Hiroyuki Sanbe gave a lecture and participated in a panel discussion, was published in Nikkei BizGate on March 22, 2024.

An article on the "NIKKEI Generative AI Symposium," in which Hiroyuki Sanbe gave a lecture and participated in a panel discussion, was published in the morning edition of the Nikkei Newspaper on March 14, 2024.

"Kagakunomori (Forest of Science): Generative AI, Symbiosis with Humanity Questioned: Interview with Experts," in which Hiroyuki Sanbe was interviewed, has been published in the Mainichi newspaper.

"[Facing AI - Regulations] the U.S. and Europe Are Strongly Conscious of Risks, and Countries Must Be Serious about Regulatory Reform and Legislation," an interview of Hiroyuki Sanbe by Kyodo News was published in member newspapers.

Joint research and development of interactive AI conducted by A&S Policy Research Institute with Deloitte and Kyoto University was featured in an article in the Nikkei Online Edition, dated November 30, 2023, published by Nikkei Inc.

Kohei Murakawa (Partner)’s comment was quoted in an article entitled "Arbitration Ambitions," in Asian Legal Business Asia Edition, October 2023, published by Thomson Reuters.

Hiroyuki Sanbe’s opinions were introduced in the book entitled “The Core of Generative AI: How to Face "New Knowledge"”, written by journalist Munechika Nishida and published by NHK publishing in September 2023.

Teruhisa Toyama (Partner)’s comment was quoted in an article entitled "Overpayment of Dividends Causes Continuous Ripples; NIDEC Reported in June, Other Companies Also Examined," in the Nikkei newspaper, dated August 21, 2023.

Takafumi Ochiai (Partner)’s comment was quoted in an article entitled "No Objection to the Classification of Drugs Requiring Supervision Not Shifting to OTC Use," in the Nikkei Medical, dated August 10, 2023.